Elevation Oncology, Inc. (ELEV)

NASDAQ: ELEV · IEX Real-Time Price · USD

2.640

-0.030 (-1.12%)

At close: Jul 19, 2024, 4:00 PM

2.730

+0.090 (3.41%)

Pre-market: Jul 22, 2024, 8:59 AM EDT

Elevation Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	144	23	22	140
Market Cap Growth	455.04%	2.90%	-84.17%	-
Enterprise Value	71	-30	-39	-6
PE Ratio	-	-0.50	-0.23	-4.36
PB Ratio	1.90	0.42	0.45	0.99
P/FCF Ratio	-5.10	-0.41	-0.26	-4.63
P/OCF Ratio	-5.10	-0.41	-0.26	-4.63
EV/EBITDA Ratio	-4.48	0.66	0.41	0.20
EV/EBIT Ratio	-4.47	0.66	0.41	0.20
EV/FCF Ratio	-3.60	0.54	0.45	0.21
Debt / Equity Ratio	0.41	0.55	0.60	-
Debt / EBITDA Ratio	-0.78	-0.66	-0.31	-
Debt / FCF Ratio	-0.63	-0.54	-0.34	-
Quick Ratio	44.58	20.05	5.75	16.64
Current Ratio	46.22	21.22	5.93	17.00
Return on Equity (ROE)	-59.30%	-81.90%	-110.30%	-30.70%
Return on Assets (ROA)	-38.50%	-48.60%	-82.00%	-23.80%
Return on Capital (ROIC)	-36.17%	-53.50%	-120.50%	-22.78%
Earnings Yield	-27.28%	-200.66%	-429.53%	-22.91%
FCF Yield	-33.92%	-246.66%	-386.56%	-21.58%
Buyback Yield / Dilution	-100.57%	-46.46%	-91.77%	-1432.24%
Total Shareholder Return	-100.57%	-46.46%	-91.77%	-1432.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).